LRCX vs ORMP
Lam Research Corp (LRCX) versus Oramed Pharmaceuticals Inc (ORMP) — a side-by-side from cached financials, not a winner call.
Lam Research Corp (LRCX) is a semiconductor equipment & materials company listed on NASDAQ.
Oramed Pharmaceuticals Inc (ORMP) is a biotechnology company listed on US.
Latest reported LRCX revenue for 2025-06-29 was $18.44B. Net income was $5.36B. LRCX currently screens at market cap $467.94B and trailing P/E 70.9.
Latest reported ORMP revenue for 2023-12-31 was $1.3M. Net income was $5.5M. Revenue was up 48.2% from 2022-12-31 to 2023-12-31. ORMP currently screens at market cap $87.2M.
LRCX currently screens at market cap $467.94B and trailing P/E 70.9. ORMP currently screens at market cap $87.2M.
Not investment advice. Open the LRCX and ORMP stock pages for the full models.
Not investment advice.